Module 2: Choosing Wisely – Personalizing Therapy in HER2-Mutant NSCLC
Explore practical strategies for personalizing therapy in HER2-mutant NSCLC. This activity examines HER2 biology, targeted treatment classes, and evidence-based care plans designed to optimize patient outcomes and interprofessional care. Learn to implement effective management today.
- Price
- Free
- Accredited provider:
- i3 Health Joint Providership
- Learning platform:
- IQ Apparatus
- Release date
- June 1, 2026
- Expires
- May 31, 2027